US 2001/0020029 A1Published application

New multidose vial formulations for administering endo-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-methyl-1H- indazole-3-carboxamide hydrochloride

AssigneeSmithKline Beecham Corporation

InventorSusan James

Life of this patent

Estimating the term…

Abstract

Invented are improved multidose aqueous formulations of endo-N-(9-methyl-9-azabicyclo[3.3.1. ]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride.

Claims14

Dependent claims

A multidose aqueous formulation comprising endo-N-(9-methyl-9-azabicyclo[3.3.1. ]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride.

Dependencies are inferred from the claim text.

Facts

Application: 09/548,838Filed 13 Apr 2000
Priority: 4 May 1998
Published: 6 Sep 2001
Term ends: Not estimatedThe source records don’t support an estimate.

Classification7 codes

A61K 9/0019
Galenical forms characterised by the site of application: injectable compositions; Intramuscular, intravenous, arterial, subcutaneous…
A61K 31/46
Having six-membered rings with one nitrogen as the only ring hetero atom: 8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
A61K 47/10
Containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides: alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene…
A61K 47/12
Containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides: carboxylic acids; Salts or anhydrides thereof

Family

Application60/084,110Us provisional application · filed 4 May 1998
Application09/304,894Continuation · filed 4 May 1999
Application09/548,838Continuation · filed 13 Apr 2000
US 6,294,548 B1Related patent
US 2001/0020029 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results